We are live on ! Find out more
IMA

ImageneBio Inc

58 hedge funds and large institutions have $142M invested in ImageneBio Inc in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

12% more funds holding

Funds holding: 5258 (+6)

0.08% more ownership

Funds ownership: 6.13%6.22% (+0.08%)

31% less capital invested

Capital invested by funds: $205M → $142M (-$63.1M)

Holders
58
Holders Change
+6
Holders Change %
+11.54%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
9
Increased
25
Reduced
9
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$21.7M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$19.3M -$3.07M -51,058 -12%
O
3
OrbiMed
New York
$13.8M
BI
4
BVF Inc
California
$13.7M
OFM
5
Omega Fund Management
Massachusetts
$9.74M
CA
6
CHI Advisors
New York
$9.44M +$296K +4,908 +3%
AG
7
Artal Group
Luxembourg
$8.01M
Verition Fund Management
8
Verition Fund Management
Connecticut
$7.45M +$3.31M +55,048 +62%
ACA
9
Avoro Capital Advisors
New York
$7.1M
BlackRock
10
BlackRock
New York
$6.26M +$897K +14,904 +14%
Vanguard Group
11
Vanguard Group
Pennsylvania
$5.86M +$1.29M +21,485 +24%
ACP
12
Acuta Capital Partners
California
$2.39M -$35K -582 -1%
LCM
13
Laurion Capital Management
New York
$2.32M +$85.8K +1,425 +3%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.24M +$251K +4,168 +11%
Adage Capital Partners
15
Adage Capital Partners
Massachusetts
$1.77M +$100K +1,667 +5%
State Street
16
State Street
Massachusetts
$1.72M +$66.2K +1,099 +3%
VVA
17
Vida Ventures Advisors
Massachusetts
$975K +$1.13M +18,766 New
Citadel Advisors
18
Citadel Advisors
Florida
$895K +$846K +14,051 +442%
Barclays
19
Barclays
United Kingdom
$894K +$21.8K +362 +2%
Northern Trust
20
Northern Trust
Illinois
$857K +$104K +1,722 +12%
NMC
21
NEA Management Company
Maryland
$707K +$911K +15,123 New
SI
22
Sofinnova Investments
California
$501K +$581K +9,643 New
BCM
23
Bridgeway Capital Management
Texas
$496K
Ensign Peak Advisors
24
Ensign Peak Advisors
Utah
$391K
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$371K +$133K +2,209 +45%

IMA Hedge Fund Activity: Q3 2023 in Review

58 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q3 2023, worth a combined $142M — down 31% from $205M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new IMA positions and 3 closed out — a net gain of 6 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was Verition Fund Management, adding an estimated $3.31M. The largest seller was Fidelity Investments, cutting an estimated $3.07M.

  • 58 institutional investors held ImageneBio Inc (IMA) as of Q3 2023, up from 52 in Q2 2023.
  • Funds reported $142M of ImageneBio Inc stock for Q3 2023, down 31% quarter-over-quarter.
  • 9 funds opened new ImageneBio Inc positions in Q3 2023 and 3 closed out, a net change of +6 holders.
  • The largest ImageneBio Inc buyer in Q3 2023 was Verition Fund Management, an estimated $3.31M added.
  • The largest ImageneBio Inc seller in Q3 2023 was Fidelity Investments, an estimated $3.07M sold.

Based on aggregated 13F filings for Q3 2023.